Stevanato Group SpA
Company Profile
Business description
Stevanato Group SpA is a provider of drug containment, drug delivery and diagnostic solutions to the pharmaceutical, biotechnology and life sciences industries. It delivers an integrated, end-to-end portfolio of products, processes, and services that address customer needs across the entire drug life cycle including development, clinical, and commercial stages. It has two segments; Biopharmaceutical and Diagnostic Solutions which generates key revenue, includes all the products, processes and services developed and provided for the containment and delivery of pharmaceutical and biotechnology drugs and reagents, as well as the production of diagnostic consumables. and its other segment is Engineering. Geographically, the company derives majority revenue from Europe, Middle East and Africa.
Contact
Via Molinella 17
Piombino Dese
Padua35017
ITAT: +39 49931811
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
31 December 2025
Employees
5,635
Stocks News & Analysis
stocks
Unconventional wisdom: A controversial income pick
stocks
How to avoid dividend disaster
stocks
Why ASX miners will handily beat banks in the long-term
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 8,780.30 | 4.80 | -0.05% |
| CAC 40 | 7,973.03 | 34.59 | -0.43% |
| DAX 40 | 21,787.00 | 115.42 | -0.53% |
| Dow JONES (US) | 44,303.40 | 444.23 | -0.99% |
| FTSE 100 | 8,700.53 | 26.75 | -0.31% |
| HKSE | 21,133.54 | 241.92 | 1.16% |
| NASDAQ | 19,523.40 | 268.59 | -1.36% |
| Nikkei 225 | 38,787.02 | 279.51 | -0.72% |
| NZX 50 Index | 12,902.19 | 57.60 | 0.45% |
| S&P 500 | 6,025.99 | 57.58 | -0.95% |
| S&P/ASX 200 | 8,511.40 | 9.30 | -0.11% |
| SSE Composite Index | 3,303.67 | 33.01 | 1.01% |